المؤلفون: Guida M., Bartolomeo N., Quaresmini D., Quaglino P., Madonna G., Pigozzo J., Di Giacomo A. M., Minisini A. M., Tucci M., Spagnolo F., Occelli M., Ridolfi L., Queirolo P., De Risi I., Valente M., Sciacovelli A. M., Chiarion Sileni V., Ascierto P. A., Stigliano L., Strippoli S.

المساهمون: Guida, M., Bartolomeo, N., Quaresmini, D., Quaglino, P., Madonna, G., Pigozzo, J., Di Giacomo, A. M., Minisini, A. M., Tucci, M., Spagnolo, F., Occelli, M., Ridolfi, L., Queirolo, P., De Risi, I., Valente, M., Sciacovelli, A. M., Chiarion Sileni, V., Ascierto, P. A., Stigliano, L., Strippoli, S.

مصطلحات موضوعية: Checkpoint inhibitor, Metastatic melanoma, Neutrophil-to-lymphocyte ratio, Platelet-to-lymphocyte ratio, Blood Platelet, Human, Immunotherapy, Lymphocyte, Prognosi, Prospective Studie, Proto-Oncogene Proteins B-raf, Retrospective Studie, Melanoma, Neutrophils

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35382857; info:eu-repo/semantics/altIdentifier/wos/WOS:000778499200004; volume:20; issue:1; firstpage:1; lastpage:15; numberofpages:15; journal:JOURNAL OF TRANSLATIONAL MEDICINE; https://hdl.handle.net/11365/1221041Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85127719534; https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03359-xTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981693Test/

الإتاحة: https://doi.org/10.1186/s12967-022-03359-xTest
https://hdl.handle.net/11365/1221041Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981693Test/

المؤلفون: Guida M., Bartolomeo N., Quaglino P., Madonna G., Pigozzo J., Di Giacomo A. M., Minisini A. M., Tucci M., Spagnolo F., Occelli M., Ridolfi L., Queirolo P., De Risi I., Quaresmini D., Gambale E., Sileni V. C., Ascierto P. A., Stigliano L., Strippoli S.

المساهمون: Guida, M., Bartolomeo, N., Quaglino, P., Madonna, G., Pigozzo, J., Di Giacomo, A. M., Minisini, A. M., Tucci, M., Spagnolo, F., Occelli, M., Ridolfi, L., Queirolo, P., De Risi, I., Quaresmini, D., Gambale, E., Sileni, V. C., Ascierto, P. A., Stigliano, L., Strippoli, S.

مصطلحات موضوعية: Checkpoint inhibitor, Immunotherapy, Melanoma, NRAS mutation

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33530579; info:eu-repo/semantics/altIdentifier/wos/WOS:000615004300001; volume:13; issue:3; firstpage:1; lastpage:15; numberofpages:15; journal:CANCERS; https://hdl.handle.net/11365/1233247Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85099938582; https://www.mdpi.com/2072-6694/13/3/475Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865301Test/

الإتاحة: https://doi.org/10.3390/cancers13030475Test
https://hdl.handle.net/11365/1233247Test
https://www.mdpi.com/2072-6694/13/3/475Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865301Test/

المؤلفون: Guida M., Bartolomeo N., Quaresmini D., Quaglino P., Madonna G., Pigozzo J., Di Giacomo A. M., Minisini A. M., Tucci M., Spagnolo F., Occelli M., Ridolfi L., Queirolo P., De Risi I., Valente M., Sciacovelli A. M., Chiarion Sileni V., Ascierto P. A., Stigliano L., Strippoli S.

المساهمون: Guida M., Bartolomeo N., Quaresmini D., Quaglino P., Madonna G., Pigozzo J., Di Giacomo A.M., Minisini A.M., Tucci M., Spagnolo F., Occelli M., Ridolfi L., Queirolo P., De Risi I., Valente M., Sciacovelli A.M., Chiarion Sileni V., Ascierto P.A., Stigliano L., Strippoli S.

مصطلحات موضوعية: Checkpoint inhibitor, Metastatic melanoma, Neutrophil-to-lymphocyte ratio, Platelet-to-lymphocyte ratio, Blood Platelet, Human, Immunotherapy, Lymphocyte, Prognosi, Prospective Studie, Proto-Oncogene Proteins B-raf, Retrospective Studie, Melanoma, Neutrophils

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35382857; info:eu-repo/semantics/altIdentifier/wos/WOS:000778499200004; volume:20; issue:1; firstpage:159; lastpage:166; numberofpages:8; journal:JOURNAL OF TRANSLATIONAL MEDICINE; http://hdl.handle.net/2318/1863384Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85127719534

الإتاحة: https://doi.org/10.1186/s12967-022-03359-xTest
http://hdl.handle.net/2318/1863384Test

المؤلفون: Guida M., Bartolomeo N., Quaglino P., Madonna G., Pigozzo J., Di Giacomo A. M., Minisini A. M., Tucci M., Spagnolo F., Occelli M., Ridolfi L., Queirolo P., De Risi I., Quaresmini D., Gambale E., Sileni V. C., Ascierto P. A., Stigliano L., Strippoli S.

المساهمون: Guida, M., Bartolomeo, N., Quaglino, P., Madonna, G., Pigozzo, J., Di Giacomo, A. M., Minisini, A. M., Tucci, M., Spagnolo, F., Occelli, M., Ridolfi, L., Queirolo, P., De Risi, I., Quaresmini, D., Gambale, E., Sileni, V. C., Ascierto, P. A., Stigliano, L., Strippoli, S.

مصطلحات موضوعية: Checkpoint inhibitor, Immunotherapy, Melanoma, NRAS mutation

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33530579; info:eu-repo/semantics/altIdentifier/wos/WOS:000615004300001; volume:13; issue:3; firstpage:1; lastpage:15; numberofpages:15; journal:CANCERS; http://hdl.handle.net/11586/357318Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85099938582

الإتاحة: https://doi.org/10.3390/cancers13030475Test
http://hdl.handle.net/11586/357318Test

المؤلفون: Guida M., Bartolomeo N., Quaglino P., Madonna G., Pigozzo J., Di Giacomo A. M., Minisini A. M., Tucci M., Spagnolo F., Occelli M., Ridolfi L., Queirolo P., De Risi I., Quaresmini D., Gambale E., Sileni V. C., Ascierto P. A., Stigliano L., Strippoli S.

المساهمون: Guida M., Bartolomeo N., Quaglino P., Madonna G., Pigozzo J., Di Giacomo A.M., Minisini A.M., Tucci M., Spagnolo F., Occelli M., Ridolfi L., Queirolo P., De Risi I., Quaresmini D., Gambale E., Sileni V.C., Ascierto P.A., Stigliano L., Strippoli S.

مصطلحات موضوعية: Checkpoint inhibitor, Immunotherapy, Melanoma, NRAS mutation

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33530579; info:eu-repo/semantics/altIdentifier/wos/WOS:000615004300001; volume:13; issue:3; firstpage:1; lastpage:15; numberofpages:15; journal:CANCERS; http://hdl.handle.net/2318/1792981Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85099938582

الإتاحة: https://doi.org/10.3390/cancers13030475Test
http://hdl.handle.net/2318/1792981Test